LinusAD

LinusAD predicts brain amyloid-beta status on PET in humans (AUC=0.882).

“Aβ‐status prediction by LinusAD (AUC=0.882) was equivalent to BBMs (AUC=0.775–0.887; average AUC=0.82) and superior to MMSE (AUC=0.71).”

HumansBio-Hermes-001 cohortn = 930

Streamlining Recruitment for AD Clinical Trials: Concurrent Detection of Cognitive Impairment and Amyloid‐Beta PET Status with a Machine Learning‐Enabled Digital Cognitive Assessment

AAIC 2025 abstract·23 Dec 2025